期刊文献+

趋化因子CCL20在慢性乙型肝炎活检组织中的表达及意义 被引量:4

Siguificance of CCL20 expression in liver biopsies of chronic hepatitis B patients
原文传递
导出
摘要 目的研究慢性乙型肝炎(CHB)肝活检组织CCL20的表达与病理分级分期的关系,探讨CCL20在慢性HBV感染中的作用及意义。方法通过内参照竞争逆转录聚合酶链反应(RT-PCR)对处于正常状态和慢性感染状态的肝细胞系的CCL20mRNA进行定量检测,观察CCL20的表达差异。定量检测正常肝脏和CHB活检组织的CCL20水平,结合肝脏组织学积分研究其相关性。结果在体外细胞系水平上,HBV未感染肝细胞HepG2的CCL20表达量为(2.65±0.02)pg/10^6细胞,而HBV持续感染肝细胞HepG2.2.15的CCL20表达量为(1.22±0.04)pg/10^6细胞(t=39.66,P〈0.01);PMA刺激CCL20表达的增加但不改变CCL20在二类细胞之间的表达格局。在HBV慢性感染状态下肝活检组织的CCL20的表达(3.54±0.65)pg/20mg显著低于其在正常肝组织中的平均表达量(8.74±0.56)pg/20mg(t=30.09,P〈0.01),且与肝脏的组织学积分相关(r=0.675,P=0.023)。结论HBV慢性感染状态下CCL20的表达下调,CCL20的表达与CHB患者肝脏组织学积分相关。 Objective To observe the correlation of histologicalactivity(HAI) of chronic hepatitis B (CHB)with CCL20 expression,and to investigate the impact of CCL20 expression in CHB infection. Methods On the basis of established competitive quantitative RT-PCR with an internal standard, the expression of the CCL20 in the hepatocytes in different infected patterns of HBV infected cells and liver biopsies were quantified and at the same time its correlation to HAI were explored. Results In the cell levels, the expression quantity of CCL20 in control cells (HepG2), persistent HBV infected hepatocytes (HepG2.2. 15) are (2. 65±0. 02) pg/10s cells, (1.22±0. 04) pg/10s cells, respectively. There were significantly differences between them (t = 39.66, P〈0.01). The expression of CCL20 was enhanced in hepatocytes stimulated by PMA but their expression pattern was not changed. Moreover, CCL20 expression in liver biopsies with CHB was (3.54±0. 65) pg/20 mg and CCL20 expression in control groups was (8. 74±0. 56) pg/20 rag. The expression of CCL20 between two groups was different (t=30. 09, P〈0.01) and correlation lied in between HAI and CCL20 expression in liver biopsies of CHB patients (r=0.675, P=0.023). Conclusion CCL20 expression was down-regulated and it was correlated to HAI of liver biopsies in CHB patients.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2008年第8期864-867,共4页 Chinese Journal of Laboratory Medicine
关键词 肝炎 乙型 慢性 趋化因子 CCL20 活组织检查 逆转录聚合酶链反应 Hepatitis B, chronic Chemokine CCL20 Biopsy Reverse transcriptase poly merase chain reaction
  • 相关文献

参考文献17

  • 1Bertoletti A, Maini MK. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Microbiol, 2000, 3: 387-392. 被引量:1
  • 2Ando K, Guidotti LG, Wirth S, et al. Class Ⅰ-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol, 1994, 152: 3245-3253. 被引量:1
  • 3Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol, 1995,13: 29-60. 被引量:1
  • 4Hieshima K, Imai T, Opdenakker G, et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem, 1997, 272: 5846-5853. 被引量:1
  • 5Furumoto K, Soares L, Engleman EG, et al. Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. J Clin Invest, 2004, 113: 774-783. 被引量:1
  • 6Crittenden M, Gough M, Harrington K, et al. Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity. Cancer Res, 2003, 63: 5505-5512. 被引量:1
  • 7叶巍,邵先安,郑秀娟,陈习武,储以微,熊思东.定量检测CCL20的竞争性内参照RT-PCR的建立及其初步应用[J].复旦学报(医学版),2005,32(3):359-364. 被引量:3
  • 8丁晓然,杨静,伯晓晨,张敏丽,陈苏红,王升启.靶向ASGPR的反义核酸与抗HBV药物联合用药的体外抗HBV作用[J].病毒学报,2006,22(1):17-21. 被引量:6
  • 9邵先安,叶巍,郑秀娟,陈习武,储以微,熊思东.HBV感染对趋化因子CCL20表达的影响及其意义[J].中华微生物学和免疫学杂志,2005,25(5):351-356. 被引量:9
  • 10Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1981,1:431-435. 被引量:1

二级参考文献41

  • 1金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73. 被引量:118
  • 2Doong S L,Tsai C H,Schinazi R F,et al.Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues[J].Proc Natl Acad Sci USA,1991,88:8495-8499. 被引量:1
  • 3De Clercq E.Perspectives for the treatment of hepatitis B virus infections[J].Int J Antimicrob Agents,1999,12(2):81-95. 被引量:1
  • 4Yang J,Bo X C,Ding X R,et al.Antisense oligonucleotides targeted against asialoglycoprotein receptor(ASGPR)block human hepatitis B virus replication[J].J Viral Hepatitis.(in press). 被引量:1
  • 5Delaney W E,Yang H,Miller M D,et al.Combination of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro[J].Antimicrob Agents Chemother,2004,48(10):3702-3710. 被引量:1
  • 6Sells M A,Zelent A Z,Shvartsman M,et al.Replication of hepatitis B virus in HepG2 cells that produce infectious virions[J].J Virol,1988,62:2836-2844. 被引量:1
  • 7Heijtink R A,De Wilde G A,Kruining J,et al.Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine(PMEA)on human and duck hepatitis B virus infection[J].Antiviral Research,1993,21:141-153. 被引量:1
  • 8Wu G Y,Wu C H.Receptor-mediated gene delivery and expression in vivo[J].J Biol Chem,1988,263(29):14621-14624. 被引量:1
  • 9Treichel U,Meyer zum Buschenfelde K H,Stockert R J,et al.The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers[J].J Gen Virol,1994,75:3021-3029. 被引量:1
  • 10Treichel U,Meyer zum Büschenfelde K H,Dienes H P,et al.Receptor-mediated entry of hepatitis B virus particles into liver cells[J].Arch Virol,1997,142:493-498. 被引量:1

共引文献15

同被引文献44

  • 1叶巍,邵先安,郑秀娟,陈习武,储以微,熊思东.定量检测CCL20的竞争性内参照RT-PCR的建立及其初步应用[J].复旦学报(医学版),2005,32(3):359-364. 被引量:3
  • 2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830
  • 3Ando K,Guidotti LG,Wirth S,et al. Class I-restricted eytotoxic T lymphoeytes are direetlyeytopathic for their target cells in vivo [J]. J Immunol, 1994, 152 (7) : 3245-3253. 被引量:1
  • 4Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis[J]. Annu Rev Immunol, 1995,13 : 29-60. 被引量:1
  • 5Hieshima K, Imai T, Opdenakker G, et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2[J]. J Biol Chern, 1997, 272(9):5846-5853. 被引量:1
  • 6Crittenden M ,Gough M ,Harrington K,et al. Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity [J]. Cancer Res, 2003, 63 (17) : 5505-5512. 被引量:1
  • 7Knodell RG, Ishak KG, Black WC,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [J]. Hepatology, 1981,1 (5) :431-435. 被引量:1
  • 8Yuen MF,Ng IO,Fan ST,et al. Significance of HBV DNA levels in liver histology of HBeAg and Anti- HBe positive patients with chronic hepatitis B [J]. Am J Gastroenterol, 2004,99 (10) : 2032-2037. 被引量:1
  • 9Ebert LM,Mccoll SR. Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4^+ T lymphocytes [J ]. J Immunol, 2002,168 (1) :65-72. 被引量:1
  • 10Caux C,Vanbervliet B,Massacrier C,et al. Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function[J]. Exp Dermatol, 2002,11 (2) :135-142. 被引量:1

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部